期刊文献+

中药走向国际的若干策略与途径 被引量:9

Some Measure Taken in March of Traditional Chinese Medicine on International Arena
下载PDF
导出
摘要 分析中草药国际市场的现状,结合作者的实际工作体会,提出中药走向国际的策略、途径和具体办法;首先考虑向有代表性的国际植物药市场(如美国)推出精心组方、适应症独特、并具有显著临床疗效的中草药;培育一批跨国医药集团公司并使其成为中药国际化工作的主要推动者;建立一流的中药研究中心——合同研究机构,为中药走向国际提供技术保障。 This article analyzes the international status quo of Chinese herbal medicines and sets forward the strategies, approaches and concrete measures in the march of traditional Chinese medicine on international arena in combination with the authors' practical working experience, e. i., first of all, it is considered to introduce to international representative markets such as those in the USA, herbal medicines which are elaborately prescribed and adapted to unique syndromes and have remarkable clinical effects; then a number of transnational pharmaceutical corporations are to be cultivated, which should become the principal organizations to push ahead the internationalization of traditional Chinese medicine; and first - class research centers of Chinese herbal medicines - - - contractual research institutions are to be set up in order to provide technical guarantee for Chinese herbal medicines to march on international arena.
出处 《世界科学技术-中医药现代化》 2004年第1期43-47,共5页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
关键词 中国 中药产业 国际竞争力 研究机构 植物药 制药企业 Chinese herbal medicine, internationalization, strategy, plant medicine, contractual research institution
  • 相关文献

参考文献11

  • 1冯崇廉.我国加入WTO后中药产业的发展契机[J].中药材,2001,24(3):206-207. 被引量:8
  • 2中国科学院.高科技发展报告[M].北京:科学出版社,2001.175.
  • 3贾伟,高文远,段宏泉,肖培根.中药国际化探讨[J].中国中药杂志,2002,27(9):645-648. 被引量:11
  • 4Yan Xijun. GAP, GMP and modernization of Traditional Chinese Drugs. International Senior Forum of Traditional Chinese Medicines & Botanical, Hangzhou, 2001, 85-90.
  • 5Eric Chen. Traditional Chinese Medicine in thd US Marker and Regulatory Considerations. International Senior Forum of Traditional Chinese Medicines & Botanical,Hangzhou, 2001, 223 - 224.
  • 6Tom Du, Charde Dai. Evaluation of Drug Related Adverse Events during the US. International Senior Forum of Traditional Chinese Medicines & Botanical, Hangzhou,2001, 206 - 209.
  • 7Jiang Y, Wang Yf, Yan X.J. Chinese pharmaceutical companies: an emerging industry. DDT, 2001, 6( 12): 610.
  • 8Yuan IL Lin Y. Traditonal Chinese Medicine:an approach to scientific proof and clinical validation. Pharmacology & Therapeutics,2000, 86: 191.
  • 9Chan K. Progress in traditional Chinese medicine. TIPS, 1995, 16: 182.
  • 10Edzard Ernst. Toxic heavy metals and un declared drugs in Asian herbalmedicines. TRENDS in Pharmacological Science, 2002, 23 (3) : 136.

二级参考文献4

共引文献17

同被引文献61

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部